How many studies have been conducted on Alpha 1 Antichymotrypsin?

BiohacksAI has indexed 300 PubMed studies on Alpha 1 Antichymotrypsin. 37% of studies involve human subjects.

What are the main research areas for Alpha 1 Antichymotrypsin?

The primary research domains for Alpha 1 Antichymotrypsin are 🧠 Neuroprotection, 🔬 Oncology, 🫁 Liver & Detox. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Alpha 1 Antichymotrypsin

The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily.

300+ PubMed studies analyzed · Evidence Score: 50

Research Domains

Alpha 1 Antichymotrypsin has been studied across 19 research domains including 🧠 Neuroprotection, 🔬 Oncology, 🫁 Liver & Detox, 🔬 Inflammation, 🫁 Respiratory. The primary research focus is 🧠 Neuroprotection with 27% of studies addressing this area.

Loading evidence profile...

This evidence profile for Alpha 1 Antichymotrypsin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.